TPWA
HALO icon

Twin Peaks Wealth Advisors’s Halozyme HALO Stock Holding History

Twin Peaks Wealth Advisors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.3K Buy
+51
New +$3.6K ﹤0.01% 1540
2025
Q3 		– Sell
-53
Closed -$3.39K – 993
2025
Q2 		$3.39K Buy
+53
New +$3.02K ﹤0.01% 1463

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Twin Peaks Wealth Advisors's HALO Position: Q1 2026 in Review

Twin Peaks Wealth Advisors opened a new position in Halozyme (HALO) in Q1 2026: 51 shares worth $3.3K. The stake represents ﹤0.01% of the portfolio and ranks #1540 among its holdings. This is a return to the name: Twin Peaks Wealth Advisors previously reported a position in HALO as recently as Q2 2025.

Twin Peaks Wealth Advisors first reported a position in HALO in Q2 2025 and has held it in 2 quarters since. The position peaked at $3.39K in Q2 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Twin Peaks Wealth Advisors held 51 shares of Halozyme worth $3.3K as of Q1 2026.
  • Halozyme was a new Twin Peaks Wealth Advisors position in Q1 2026.
  • Halozyme made up ﹤0.01% of Twin Peaks Wealth Advisors's portfolio in Q1 2026, its #1540 holding.
  • Twin Peaks Wealth Advisors first reported a position in Halozyme in Q2 2025 and has held it in 2 quarters since.
  • Twin Peaks Wealth Advisors's Halozyme position peaked at $3.39K in Q2 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Twin Peaks Wealth Advisors's 13F filing for Q1 2026, filed 8 May 2026.